A mouse lymphokine that stimulates the production of functional eosinophils in liquid bone marrow cultures has recently been described [Sanderson, C.
for this molecule, and we suggest the defining property should be its eosinophil-differentiating activity.
The study of lymphokines has evolved from testing crude lymphocyte supernatants containing a multitude of factors to the stage where well-defined preparations can be tested in well-defined assays. This has led to "convergence" as differing lymphokine activities are found to be different properties of a restricted group of molecules. For example, t-interferon (IFN-y) inhibits viral replication, activates macrophages, increases expression of class 2 antigens of the major histocompatibility complex and is involved in B-cell activation (1) (2) (3) (4) (5) ; interleukin 3 (IL-3) has been shown to exhibit activity in many bioassays (6) , and at least a dozen names based on different assays are used for this factor (7, 8) ; interleukin 2 (IL-2), originally described as a T-cell growth factor (9) , has been shown to have B-cell growth factor (BCGF) activity (10) . These examples illustrate the difficulties that can be encountered when lymphokine names are based on assay systems.
In this report we present evidence indicating that eosinophil differentiation factor (EDF) (11) , stimulates the B-cell tumor (BCL1) cell line that is used to define BCGFII (12) . We were first alerted to the possibility that these two assays may be detecting a single lymphokine when a coordinate analysis of lymphokines produced by T-cell clones revealed a highly significant correlation between eosinophil differentiation activity [EDA; i.e., activity in the assay, the main component of which is EDF (1)] and BCGFII activity. This was strengthened by the fact that various cell lines producing high levels of one of the factors were also high for the other. The possibility that a single lymphokine was involved is further suggested by biochemical separations of EDF produced by the T-cell hybrid (NIMP-THi) that had been selected for the production of this lymphokine (13) .
MATERIALS AND METHODS
T-Cell Cloning. Alloreactive T-cell clones were isolated as described (14) . Briefly, BALB/c.nimr spleen cells were cultured in microplates at limiting dilution (100 cells per well) with 2 x 105 irradiated CBA.nimr spleen cells per well and a source of IL-2. After 2 weeks in culture the clones were restimulated with irradiated T-cell-depleted CBA spleen cells in the absence of exogenous IL-2, and supernatants were collected after 48 hr.
Lymphokine Assays. All assays were carried out in microplates. IL-3 was assayed on the dependent hemopoietic cell line 32D, using the incorporation of [3H]thymidine to determine cell growth (15 (17) . Growth was determined as in the BCGFI assay. EDA was assayed by incubating bone marrow cells from Mesocestoides corti-infected mice (105 per well) with test material. After 5 days eosinophils produced in the cultures were determined by assay for eosinophil peroxidase (18, 19) .
Fractionation. Gel filtration was carried out on a 300 ml bed column of Ultrogel AcA 54 (LKB, Croydon, Surrey) in phosphate-buffered saline (0.15 M NaCl/0.02 M sodium phosphate, pH 7.4) containing polyethylene glycol (PEG 6000; BDH Pharmaceuticals, Poole, Dorset) at 50 ,ug/ml. The column was calibrated with bovine serum albumin (Mr = 66,000), ovalbumin (Mr = 45,000), carbonic anhydrase (Mr = 30,000), and cytochrome c (Mr = 12,400) (all from Sigma). Separation by binding to lentil lectin was carried out using LcA-Sepharose (Pharmacia, Uppsala, Sweden) and eluting with 0.1 M methyl a-mannoside. Reverse-phase HPLC was carried out on a ABondapak C18 column (Waters Associates).
The column was eluted with acetonitrile containing 0.1% trifluoroacetic acid, from 25% to 40% (vol/vol) acetonitrile, and then from 40% to 60% acetonitrile.
RESULTS
Conditioned medium from 39 alloreactive T-cell clones were tested for their ability to stimulate eosinophil differentiation and compared with activity in the BCGFI (B-cell-stimulatory Abbreviations: IFN--y, t-interferon; IL-2, interleukin 2; IL-3, interleukin 3; BCGF, B-cell growth factor; EDF, eosinophil differentiation factor; EDA, eosinophil differentiation activity (i.e., activity in the assay, the main component of which is EDF); CSF, colonystimulating factor; TH1-CM, conditioned medium from the T-cell hybrid NIMP-TH1; T2-CM, conditioned medium from the T-cell clone NIMP-T2.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. factor 1, BSF-1) and BCGFII assays (Fig. 1) . Regression analysis indicated that there was no significant correlation between EDA and BCGFI production (P > 0.05), whereas the relationship between the production of EDA and BCGFII was highly significant (P < 0.001). This positive correlation could indicate either that the two lymphokines were under coordinate control or that a single molecule was involved.
As shown in Table 1 the T-cell hybrid NIMP-TH1, which was known not to produce IL-2, IL-3, colony-stimulating factor (CSF), or IFN--y (13), was found to have BCGFII activity. Another T-cell hybrid (NIM-TH12) that had been selected for BCGFII activity was found to produce high levels of EDF. In addition, two sublines of the EL4 cell line, both producing high levels of IL-2 but differing markedly in BCGFII production, were found to show a similar difference in their capacity to produce EDF. Also, the T-cell clone (NIMP-T2) maintained as a high producer of EDF (11) was a high producer of BCGFII.
These results provided circumstantial evidence that EDF and BCGFII might be properties of a single molecule, and so fractionation experiments were undertaken. First, gel filtration of NIMP-TH1 conditioned medium (TH1-CM) and NIMP-T2 conditioned medium (T2-CM) showed that in each case the EDA and BCGFII activities had similar elution patterns (Fig. 2) , with a peak equivalent to Mr 46,000. IL-3, also present in T2-CM, eluted with a peak of Mr 29,000, as shown previously (11) . Fractionation of TH1-CM by lentil lectin affinity chromatography, flat-bed isoelectric focusing, preparative gel electrophoresis, and elution from phenylSepharose and DEAE-Sepharose showed that in each case EDF and BCGFII had identical elution profiles (data not shown). Material purified by gel filtration and then by affinity chromatography on lentil lectin was subjected to reversephase HPLC. The two activities coincided (Fig. 3 ).
DISCUSSION
The identification of EDF was aided by the construction of a T-cell hybrid (NIMP-TH1) that appeared not to produce any other lymphokines (13) . This made it relatively easy to show that EDF was distinct from IL-2, IFN-y, IL-3, and factors stimulating neutrophil and macrophage colony formation. undifferentiated bone marrow precursor cells in liqi ture. These culture-derived eosinophils have similar l 1 eosinophil peroxidase and express receptors for th range of immunoglobulin isotypes as eosinophils tak mice. They have the capacity to kill antibody-and c ment-coated schistosomula of Schistosoma manso These results indicate that EDF controls differentifully mature and activated eosinophils. Furthermore,: EDF is also active on human cells in a lineage-specif inducing proliferation, differentiation, and activa eosinophils, with no detectable effect on neutrophilsI lished data).
On the other hand, BCGFII was originally describ( activity (DL-BCGF), produced by an alloreactive T-c which could be assayed on normal B cells and BCL cells (12) . Subsequently a similar activity was r purified from media conditioned by the lymphoma ( EL4 (EL4-BCGFII) with Mr (gel filtration) of 55,0 This factor is distinct from a lower molecular weigh (16) also produced by EL4 cells (BCGFI, EL4-] BSF-1).
As part of a series of experiments designed to st expression of multiple lymphokines by T cells a co( analysis of the production of lymphokines by T-cel was carried out. There was no correlation between E IL-2, IL-3, CSF, or IFN-,y (20) . However, there wa correlation between EDA and BCGFII (Fig. 1) . This, 1.0 er with the results showing that the two activities copurify 1.0 ( Figs. 2 and 3) , strongly suggests that the activities are the property of a single species of molecule. Although the Mr°e stimate of 55,000 for BCGFII from EL4 (17) is higher than the value obtained in this paper from TH1-CM and T2-CM 0.5 .
(45,000) the elution profile is wide, suggesting some heterogeneity. Furthermore, our studies with EL4 supernatants indicate that EDF and BCGFII from this source co-elute with mean Mr of 45,000 (unpublished data). Thus it seems likely that the disparity can be attributed to technical differences. 0 Complete purification of EDF will allow more accurate estimates of molecular size.
Although in this work the ability to stimulate DNA synthesis in BCL1 cells has been used as an assay for BCGFII activity, other experiments with semi-purified material from TH1-CM showed that EDF induces DNA synthesis in large B cells (preactivated in vitro) and in B cells activated by anti-immunoglobulin in vitro (unpublished data). These experiments suggest that this factor acts on B cells at a late stage in G, phase and confirm a direct activity on B cells rather than EDF.
- 50 The biological role for these divergent activities residing in one lymphokine can only be speculated upon at the present 40 time. It is interesting to recall that eosinophilia is frequently associated with high levels of IgE antibody, which raises the°p ossibility that this association may be linked to the different -20 biological activities of this lymphokine. This work raises the problem of nomenclature for this -10 lymphokine. The term "IL-2" has been readily accepted for the factor originally defined as a T-cell growth factor, and the term "IL-3" is gaining acceptance for what has been a confusing array of functional names. Indeed, the naming of LC. The EDF is complicated by the fact that IL-3 also has activity in Ltion on this assay (11) . For these reasons we propose the name d passed "interleukin 4" for the factor we originally described as EDF umn was (11) . The eosinophil-differentiating property appears to be the ntration most appropriate defining characteristic at the present time. esults of Functionally active eosinophils are produced in vitro, it can be GFII (of detected in the serum of mice with eosinophilia (19) , and it induces an increased number ofeosinophils in the bone marrow when injected into normal mice (unpublished data). On the other hand, the role of its BCGF activity is not as well defined. uid culevels of e same en from c.omplePni (11 
